About Michael Levy, MD, PhD

Dr. Michael Levy, MD, PhD, is an Associate Professor of Neurology at Massachusetts General Hospital and Research Director of the Division of Neuroimmunology & Neuroinfectious Disease. He completed the MD/PhD program at Baylor College of Medicine (Houston, TX) with a focus on neuroscience. Dr. Levy completed his Johns Hopkins internship in the Osler Medicine program, residency in the Johns Hopkins Neurology program and a fellowship in Neuroimmunology at Johns Hopkins University. In 2009, Dr. Levy was appointed to the faculty as Assistant Professor at Johns Hopkins where he started the Neuromyelitis Optica Clinic and Research Laboratory and in 2019 he moved to the Massachusetts General Hospital and Harvard Medical School to develop the research program in neuroimmunology. 

 Clinically, Dr. Levy specializes in taking care of patients with rare neuroimmunological diseases including neuromyelitis optica, transverse myelitis, MOG antibody disease, acute disseminated encephalomyelitis and optic neuritis. In addition to neuroimmunology clinics, Dr. Levy has a special interest in patients with superficial siderosis of the central nervous system. Dr. Levy is the principal investigator on several clinical studies and drug trials for all of these conditions.

In the laboratory, Dr. Levy’s research focuses on the development of animal models of neuromyelitis optica and transverse myelitis with the goal of tolerization as a sustainable long term treatment.

Departments, Centers, & Programs:

Clinical Interests:



Neurology Associates
15 Parkman Street
Boston, MA 02114-3117

Medical Education

  • MD, PhD, Baylor College of Medicine
  • Residency, The Johns Hopkins Hospital
  • Fellowship, The Johns Hopkins Hospital

American Board Certifications

  • Neurology, American Board of Psychiatry and Neurology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


View my most recent research

The Levy Lab is focused on understanding the immunopathogenic mechanisms of rare autoimmune diseases of the central nervous system including neuromyelitis optica, transverse myelitis and MOG antibody disease. We have expertise in animal models of these diseases which we also use to study pathogenic mechanisms of autoimmunity. The goal to translate our findings to human trials is driven by the unmet need in the neuroimmunology clinic.